August 09, 2023
2 min watch
Save
VIDEO: Antiresorptive drugs can address bone loss with cancer therapies
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SANTA FE, N.M. — In this video exclusive, Azeez Farooki, MD, discusses considerations when dealing with bone loss and elevated fracture risk resulting from treatments for breast and prostate cancer.
Farooki, an endocrinologist, is an attending physician at Memorial Sloan Kettering Cancer Center in New York.
“It’s important to communicate with our oncology colleagues to collaborate and form treatment plans and help them manage fracture risk in both of these types of cancer patients,” Farooki told Healio.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Farooki reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.